Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a company focused on developing unique, life-saving medical products, is featured in the latest episode of InvestorBrandNetwork’s Stock2Me podcast. Hosted by Stuart Smith, the podcast talks with soccer play Abby Wambach, an Olympic gold medalist and member of ODYY’s sports advisory board. During the interview, Wambach discusses her soccer career and why she was drawn to Odyssey, a medical technology company that is developing a drug/device combination intended to treat concussion. Wambach and other members of the sports advisory board support the company’s efforts to enhance public awareness of traumatic brain injuries and concussions and the need for an FDA-approved therapy. The Stock2Me Podcast is part of IBN’s sustained effort to provide specialized content distribution via widespread syndication channels; the podcast features a variety of companies and individuals, many of whom are actively revolutionizing age-old business practices within their respective markets. “There’s just so little research done not only on concussions themselves but also when you break it down into the genders,” said ODYY sports advisory board member Abby Wambach in the press release. “So many less dollars get siphoned over to the women’s side, not only because it’s newer in terms of the history of sport, but because women historically haven’t been given the same amount of research dollars to figure out what’s going on with their bodies and why. . . . That’s why I partnered with Jake [Vanlandingham] and the Odyssey crew, because it’s so important not only to the rest of my life but to make sure that our kids are playing sports in the most safe and healthy way. It’s really important to talk about this and be in the proactive lane to be able to somehow solve this issue of head trauma and concussions in sport.”
To hear the full podcast, the full interview, visit https://ibn.fm/TGpqk
To view the full press release, visit https://ibn.fm/hXGca
About Odyssey Health Inc.
Odyssey Health is a medical company with a focus in the area of life-saving medical solutions. Odyssey’s corporate mission is to create, acquire and develop distinct assets, intellectual property, and exceptional technologies that provide meaningful medical solutions. The company is focused on areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity.
NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.